Question 1

Which countries lead Internal Medicine research?

Accepted Answer

On research quality in 2022-now, the United States, Germany and China rank highest in Internal Medicine. By volume, the United States and China publish the most (4.2k and 1.8k works in 2022-now).

Question 2

Which institutions lead Internal Medicine research?

Accepted Answer

Harvard University (United States) ranks first in Internal Medicine on research quality in 2022-now, followed by Mayo Clinic and Capital Medical University.

Question 3

Who are the leading researchers in Internal Medicine?

Accepted Answer

Counting only their work in Internal Medicine, Samuel Zachary Goldhaber, Gregory Y.H. Lip and Frederikus Albertus Klok have the most papers in the world top 10% for their subfield and year beyond the 10% expected.

Question 4

Where is Internal Medicine research done?

Accepted Answer

The largest centres of Internal Medicine research in 2022-now are Beijing (China), New York (United States), London (United Kingdom) and Boston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Maywood and New Hyde Park.

Question 5

Where is the best place to study Internal Medicine?

Accepted Answer

Among universities, judged by research, Harvard University, McMaster University and Leiden University score highest, combining standing in the field's ranking, excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

Question 6

Is Internal Medicine research growing?

Accepted Answer

Output in 2022-2025 was 0% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are Venous Thromboembolism Diagnosis and Management.

Question 7

What are the most cited papers in Internal Medicine?

Accepted Answer

The most cited paper in Internal Medicine is "Correspondence - Tranexamic acid for traumatic brain injury" (Marina Romanello et al., 2005), with 11,912 citations. Next come "Dabigatran versus Warfarin in Patients with Atrial Fibrillation" (11,272) and "Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach" (6,816).